Search results
Results From The WOW.Com Content Network
American law requires that certain drugs and biological products must be labelled very specifically. Title 21, Part 201.57 (9)(i) of the Code of Federal Regulations lists specific requirements regarding the labeling of drugs with respect to their effects on pregnant populations, including a definition of a "pregnancy category".
Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. [ 4 ] [ 6 ] It is available as a generic medication . In 2022, it was the 103rd most commonly prescribed medication in the United States, with more than 6 million prescriptions.
This is a list of progestogens (progesterone and progestins) and formulations that are approved by the FDA Tooltip Food and Drug Administration in the United States. Progestogens are used as hormonal contraceptives, in hormone replacement therapy for menopausal symptoms, and in the treatment of gynecological disorders.
This is a complete list of estrogens and formulations that are approved by the FDA Tooltip Food and Drug Administration and available in the United States. Estrogens are used as hormonal contraceptives , in hormone replacement therapy , and in the treatment of gynecological disorders .
Misoprostol is approved for medical abortion regimens when administered at the office, but clinicians often give abortion patients the drug to be taken at home. [ 15 ] Modafinil is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy , shift work sleep disorder , and obstructive sleep apnea .
Mifepristone, and also known by its developmental code name RU-486, is a drug typically used in combination with misoprostol to bring about a medical abortion during pregnancy. [8] This combination is 97% effective [ 9 ] during the first 63 days (9 weeks) of pregnancy , yet effective in the second trimester as well.
There is tentative evidence that typical doses of inhaled steroids and LABAs are safe in pregnancy. [9] Both formoterol and budesonide are excreted in breast-milk. [1] Budesonide/formoterol was approved for medical use in the United States in 2006. [2] [10] It is on the World Health Organization's List of Essential Medicines.
Erenumab, which was developed by Amgen and Novartis, [5] was approved in May 2018, and was the first CGRPR antagonist to be approved by the U.S. Food and Drug Administration. [6] In 2020, it was the 234th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [7] [8]